
Professor
School of Medicine
+1 415 502-5753
Custom People Group
Publications
Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae - Authors' reply.
The Lancet. Infectious diseases
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.
The Lancet. Infectious diseases
Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis.
The Journal of infectious diseases
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) study.
The International journal on drug policy
Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis.
bioRxiv : the preprint server for biology
Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial.
JAMA network open
Postexposure Doxycycline for Sexually Transmitted Infections. Reply.
The New England journal of medicine
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.
Open forum infectious diseases
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis.
JAMA network open
Remdesivir for the Treatment of Covid-19 - Final Report.
The New England journal of medicine
Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence.
Alimentary pharmacology & therapeutics
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Localized US Efforts to Eliminate Hepatitis C.
Infectious disease clinics of North America
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials.
Liver international : official journal of the International Association for the Study of the Liver
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure.
Hepatology (Baltimore, Md.)
Disabling Dactylitis and Tenosynovitis Due to Mycobacterium haemophilum in a Patient With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome.
Open forum infectious diseases
Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.
Journal of clinical medicine
Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.
Open forum infectious diseases
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.
Topics in antiviral medicine
CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis.
Topics in antiviral medicine
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Annals of internal medicine
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries.
BMC infectious diseases
CROI 2016: Viral Hepatitis and Liver Fibrosis.
Topics in antiviral medicine
Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda.
The Pediatric infectious disease journal
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.
Journal of acquired immune deficiency syndromes (1999)
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
The New England journal of medicine
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
The New England journal of medicine
Bartonella quintana Aortitis in a Man with AIDS, Diagnosed by Needle Biopsy and 16S rRNA Gene Amplification.
Journal of clinical microbiology
CROI 2015: Highlights of Viral Hepatitis Therapy.
Topics in antiviral medicine
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.
Antimicrobial agents and chemotherapy
CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy.
Topics in antiviral medicine
HIV-associated central nervous system tuberculosis.
Seminars in neurology
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
Journal of acquired immune deficiency syndromes (1999)
Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.
Journal of acquired immune deficiency syndromes (1999)
Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.
Journal of clinical microbiology
Household ventilation and tuberculosis transmission in Kampala, Uganda.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy.
Topics in antiviral medicine
Complications of HIV disease and antiretroviral therapy.
Topics in antiviral medicine
Resistance patterns and response to entecavir intensification among HIV-HBV-coinfected adults with persistent HBV viremia.
Journal of acquired immune deficiency syndromes (1999)
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
The New England journal of medicine
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
American journal of respiratory and critical care medicine
Tuberculosis drug development: ensuring people living with HIV are not left behind.
American journal of respiratory and critical care medicine
Complications of HIV disease and antiretroviral therapy.
Topics in antiviral medicine
Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States.
Topics in HIV medicine : a publication of the International AIDS Society, USA
Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Tuberculosis as part of the natural history of HIV infection in developing countries.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Complications of HIV disease and antiretroviral treatment.
Topics in HIV medicine : a publication of the International AIDS Society, USA
Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.
American journal of respiratory and critical care medicine
Antiretroviral therapy and TB.
Tropical doctor
Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999)
Willing and able? Provision of medication for abortion by future internists.
Women's health issues : official publication of the Jacobs Institute of Women's Health